ArticleCancer diagnosis & prognosis
Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: Mixed epithelial and stromal tumor (MEST) is a benign renal neoplasm. For MEST cases requiring kidney transplantation, a waiting period is essential. However, reports on the management of MEST cases awaiting kidney transplantation are limited. We report the case of a patient with end-stage renal disease and bilateral renal pelvic tumors who was pathologically diagnosed with MEST and successfully underwent living-donor kidney transplantation without the recommended waiting period. Case Report: A 52-year-old woman had been diagnosed with mesangial proliferative glomerulonephritis 10 years earlier. Her renal function had gradually declined, and maintenance hemodialysis had been initiated 1 year before referral to us. She preferred living-donor kidney transplantation and was referred to our hospital after computed tomography at a previous institution revealed bilateral renal pelvic masses with well-defined margins and contrast enhancement. Voided urine cytology was classified as atypical urothelial cells. At the patient's request, ureteroscopic examination was not performed. For diagnostic and therapeutic purposes, robot-assisted left nephroureterectomy was performed. Histopathological examination revealed MEST, and this was confirmed Conclusion: This case demonstrates that living-donor kidney transplantation without a mandatory waiting period may benefit patients with end-stage renal disease when a definitive diagnosis of MEST is established before transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.